China Universal Asset Management Co., Ltd. SYRE SPYRE THERAPEUTICS INC

Ownership history in China Universal Asset Management Co., Ltd.  ·  6 quarters on record

AI Ownership Summary

China Universal Asset Management Co., Ltd. reported SPYRE THERAPEUTICS INC (SYRE) in 6 quarterly 13F filings from 2024 Q4 through 2026 Q1. Peak portfolio weight reached 0.05% in 2026 Q1. The latest visible filing shows SYRE at 0.05% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this SYRE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was China Universal Asset Management Co., Ltd.'s position in SPYRE THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

SYRE was reported at 0.05% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.05% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How China Universal Asset Management Co., Ltd. held SYRE — position size vs. price
% of Fund (quarterly)    SYRE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 13,938 +1,294 +10.2% 0.05% $703K 2026-04-28 $68.63
2025 Q4 ADDED 12,644 +2,057 +19.4% 0.03% $414K 2026-01-29 $33.58
2025 Q3 REDUCED 12.7% +94.3% 10,587 -1,535 -12.7% 0.01% $177K 2025-11-10 $22.18
2025 Q2 ADDED 12,122 +35 +0.3% 0.02% $181K 2025-08-28 $16.72
2025 Q1 REDUCED 12,087 -353 -2.8% 0.02% $195K 2025-04-30 $15.23
2024 Q4 INITIATED 12,440 0.03% $290K 2025-01-24 $21.60

FAQ About China Universal Asset Management Co., Ltd. and SYRE

These are the practical questions this page is built to answer before you even open the full history table.

How long has China Universal Asset Management Co., Ltd. reported owning SYRE?

China Universal Asset Management Co., Ltd. reported SYRE across 6 quarterly 13F filings, from 2024 Q4 through 2026 Q1.

What was the largest reported SYRE position in China Universal Asset Management Co., Ltd.'s portfolio?

The largest reported portfolio weight for SYRE was 0.05% in 2026 Q1.

What is the latest reported SYRE position on this page?

The most recent filing on this page is 2026 Q1, when China Universal Asset Management Co., Ltd. reported 13,938 shares, equal to 0.05% of portfolio, with an estimated market value of $703K.

What does the chart on this SYRE ownership page compare?

The chart compares China Universal Asset Management Co., Ltd.'s quarterly SYRE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did China Universal Asset Management Co., Ltd. time their SYRE position?

Based on 13F filing dates vs. subsequent SYRE price moves, China Universal Asset Management Co., Ltd. correctly timed 2 out of 5 reported position changes (40%). The annualised alpha on SYRE relative to SPY over the holding period was +118.8%.

← Back to China Universal Asset Management Co., Ltd. Holdings